An international multi-site trial has launched to determine whether a common anti-inflammatory drug can reduce heart attacks, strokes, and deaths due to cardiovascular disease in people at high risk for them. This study is being supported by the National Heart, Lung, and Blood Institute (NHLBI), a part of the National Institutes of Health.
URL: http://www.news-medical.net/news/20120822/CIRT-to-determine-whether-methotrexate-can-reduce-heart-attacks-strokes-and-CVD-deaths.aspx
No comments:
Post a Comment